Baker Brothers Advisors - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$4,063,000
-65.3%
60,155
-72.1%
0.03%
-68.7%
Q1 2018$11,699,000
-34.6%
215,655
-28.0%
0.10%
-36.1%
Q4 2017$17,887,000
+22.9%
299,3560.0%0.16%
+31.4%
Q3 2017$14,549,000
-7.5%
299,3560.0%0.12%
-14.5%
Q2 2017$15,731,000
+15.9%
299,3560.0%0.14%
+24.3%
Q1 2017$13,576,000
+19.8%
299,3560.0%0.11%0.0%
Q4 2016$11,331,000
+0.3%
299,3560.0%0.11%
+7.8%
Q3 2016$11,298,000
+114.4%
299,3560.0%0.10%
+87.3%
Q2 2016$5,269,000
+44.8%
299,3560.0%0.06%
+44.7%
Q1 2016$3,640,000
-50.1%
299,3560.0%0.04%
-36.7%
Q4 2015$7,289,000
+37.2%
299,3560.0%0.06%
+22.4%
Q3 2015$5,311,000
+0.5%
299,3560.0%0.05%
+6.5%
Q2 2015$5,284,000
-43.7%
299,3560.0%0.05%
-41.0%
Q1 2015$9,382,000
+7.4%
299,3560.0%0.08%
-12.4%
Q4 2014$8,738,000
+41.1%
299,3560.0%0.09%
+14.1%
Q3 2014$6,194,000
-16.5%
299,3560.0%0.08%
-14.3%
Q2 2014$7,415,000
+16.9%
299,3560.0%0.09%
+12.3%
Q1 2014$6,343,000
+17.7%
299,356
-0.2%
0.08%
+6.6%
Q4 2013$5,388,000300,0000.08%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders